Temporally controlled somatic mutagenesis in smooth muscle
✍ Scribed by Susanne Kühbandner; Sabine Brummer; Daniel Metzger; Pierre Chambon; Franz Hofmann; Robert Feil
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 417 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1526-954X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To generate temporally controlled targeted somatic mutations selectively and efficiently in skeletal muscles, we established a transgenic HSA-Cre-ER(T2) mouse line in which the expression of the tamoxifen-dependent Cre-ER(T2) recombinase is under the control of a large genomic DNA segment of the hum
## Abstract To generate temporally controlled targeted somatic mutations selectively and efficiently in hepatocytes, we established SA^+/CreERT2^ mice in which the tamoxifen‐dependent Cre‐ER^T2^ recombinase coding sequence preceded by an internal ribosomal entry site was inserted in the 3′ untransl
The cytoskeletal protein SM22alpha is expressed in visceral and vascular smooth muscle cells (SMCs), in cardiac myocytes, and in the myotomal components of the somites during murine embryonic development. In this report, we describe the generation and characterization of transgenic mice expressing C
## Abstract Magnesium‐based bioabsorbable cardiovascular stents have been developed to overcome limitations of permanent metallic stents, such as late stent thrombosis. During stent degradation, endothelial and smooth muscle cells will be exposed to locally high magnesium concentrations with yet un